PIVKA-II is a useful tool for diagnostic characterization of ...
Protein induced by vitamin K absence-II (PIVKA-II) is a potential screening marker for hepatocellular carcinoma (HCC). Limited data are available about its utility in discriminating …
PIVKA-II serves as a potential biomarker that complements AFP ...
2023年4月13日 · PIVKA-II is a promising serum biomarker for the HCC diagnosis that can be used as a supplement for AFP. The combined diagnosis of the two markers greatly improved …
PIVKA-II as a Potential New Biomarker for Hepatocellular ...
Aim: The aim of this study was to evaluate the clinical contribution of protein induced by vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) diagnostics and compare it with alpha …
Effectiveness of PIVKA-II in the detection of hepatocellular ...
2017年9月1日 · Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an efficient biomarker specific for hepatocellular carcinoma (HCC). Some researchers have proved that …
Usefulness of PIVKA-II for monitoring after liver ... - Nature
2023年4月6日 · Serum PIVKA-II levels may play an important role in predicting disease severity. Furthermore, monitoring PIVKA-II levels in HCC transplant recipients reflects the tumor early …
Elecsys ® PIVKA-II - Roche Diagnostics USA
elecsys pivka-ii and elecsys afp assays demonstrate good clinical performance for hepatocellular carcinoma (hcc) diagnosis across different disease stages and etiologies. In The Liver Meeting …
PIVKA-II or AFP has better diagnostic properties for ...
2023年2月17日 · Hepatocellular carcinoma (HCC) is a lethal cancer. Two biomarkers were used for HCC diagnosis including alpha-fetoprotein (AFP) and protein induced by vitamin K absence …